These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7220572)

  • 21. Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogs.
    Garrett ER; Altmayer P
    J Pharm Sci; 1985 Mar; 74(3):295-9. PubMed ID: 4009437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bezafibrate: lack of effect on creatinine excretion and muscular proteins.
    Mertz DP; Lang PD; Vollmar J
    Res Exp Med (Berl); 1982; 180(1):95-8. PubMed ID: 7079594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of once and 3-times daily regimens of bezafibrate in patients with primary hyperlipoproteinaemia.
    Dick TB; Marples J; Ledermann HM; Whittington J
    Curr Med Res Opin; 1981; 7(8):489-502. PubMed ID: 7030635
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of bezafibrate and clofibrate on microsomal ACAT and lysosomal cholesterol ester hydrolase activity in the cholesterol-fed rabbit aorta.
    Hudson K; Day AJ
    Atherosclerosis; 1982 Oct; 45(1):109-13. PubMed ID: 7159486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of 6 alpha-hydroxylation of taurochenodeoxycholic acid in pig liver.
    Boström H
    J Lipid Res; 1986 Aug; 27(8):807-12. PubMed ID: 3095476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of lauric acid hydroxylation and maintenance of cytochrome P-450 content by clofibrate in primary cultures of rat hepatocytes.
    Lake BG; Gray TJ; Stubberfield CR; Beamand JA; Gangolli SD
    Life Sci; 1983 Jul; 33(3):249-54. PubMed ID: 6865658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of palmotoxins B0 and G0 in vitro.
    Bassir O; Emerole GO
    Eur J Biochem; 1974 Sep; 47(2):321-4. PubMed ID: 4213246
    [No Abstract]   [Full Text] [Related]  

  • 28. Chromatographic resolution of ciprofibrate and interaction of the racemate and both enantiomers with rat liver microsomes in vitro.
    Oelschläger H; Rothley D; Klinger W; Karge E; Vogelsang H
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):323-9. PubMed ID: 9784004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters.
    Bronfman M; Amigo L; Morales MN
    Biochem J; 1986 Nov; 239(3):781-4. PubMed ID: 3827829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.
    Nielsen TL; Rasmussen BB; Flinois JP; Beaune P; Brosen K
    J Pharmacol Exp Ther; 1999 Apr; 289(1):31-7. PubMed ID: 10086984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iodine- and chlorine-containing oxidation agents as hydroxylating catalysts in cytochrome P-450-dependent fatty acid hydroxylation reactions in rat liver microsomes.
    Gustafsson JA; Bergman J
    FEBS Lett; 1976 Nov; 70(1):276-80. PubMed ID: 992072
    [No Abstract]   [Full Text] [Related]  

  • 32. A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylase.
    Swinney DC; Webb AS; Freedman R
    Biochem Pharmacol; 1991 Nov; 42(12):2341-9. PubMed ID: 1662512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of fibric acid derivatives.
    Spence JD
    Clin Pharmacokinet; 1998 May; 34(5):419-20. PubMed ID: 9592623
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of bezafibrate on the carbohydrate metabolism of 17 diabetics with hyperlipidemia].
    Stratmann FW; Holler HD; Hofmann H
    Med Welt; 1981 Feb; 32(8):268-71. PubMed ID: 7207168
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of bezafibrate and clofibrate on cholesterol ester metabolism in 3T3 cells in smooth muscle cells in tissue culture.
    Hudson K; Day AJ; Marceglia A
    Exp Mol Pathol; 1982 Apr; 36(2):156-63. PubMed ID: 7060720
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
    Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
    Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].
    Bolzano K; Krempler F; Schellenberg B; Schlierf G
    Acta Med Austriaca; 1979; 6(3):90-4. PubMed ID: 547652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-inductive effect of a hypolipidemic compound N-bis-(p-chlorophenoxy)-acetyl-urea in man and rat.
    Gógl A; Simon K; Müller D; Klinger W; Ruzsa C; Vezekényi Z
    Acta Med Acad Sci Hung; 1979; 36(1):127-36. PubMed ID: 525223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselective hydroxylation of mexiletine in human liver microsomes: implication of P450IID6--a preliminary report.
    Vandamme N; Broly F; Libersa C; Courseau C; Lhermitte M
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):77-83. PubMed ID: 7678683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of bezafibrate and clofibrate on cholesterol ester metabolism in rabbit peritoneal macrophages stimulated with acetylated low density lipoproteins.
    Hudson K; Mojumder S; Day AJ
    Exp Mol Pathol; 1983 Feb; 38(1):77-81. PubMed ID: 6832340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.